Business Description
Surface Oncology Inc
NAICS : 325412
SIC : 2834
ISIN : US86877M2098
Compare
Compare
Traded in other countries / regions
SURF.USAQSOA.Germany IPO Date
2018-04-19Description
Surface Oncology Inc is a clinical-stage immuno-oncology company. It is developing new therapies that modify the spaces in and around tumors in the tumor microenvironment to create conditions that support and sustain anti-tumor immune responses. The company's pipeline products are SRF231, SRF373, SRF617, and SRF388. Geographically, the activities are carried out throughout the region of the United States.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.93 | |||||
| Equity-to-Asset | 0.75 | |||||
| Debt-to-Equity | 0.19 | |||||
| Debt-to-EBITDA | -0.11 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -0.8 | |||||
| 3-Year EBITDA Growth Rate | 17.7 | |||||
| 3-Year EPS without NRI Growth Rate | 16.7 | |||||
| 3-Year FCF Growth Rate | 21.4 | |||||
| 3-Year Book Growth Rate | -8.8 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 62.24 | |||||
| 9-Day RSI | 62.95 | |||||
| 14-Day RSI | 61.5 | |||||
| 6-1 Month Momentum % | 41.68 | |||||
| 12-1 Month Momentum % | -31.44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | |||||
| Quick Ratio | 3.6 | |||||
| Cash Ratio | 3.34 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -29.5 | |||||
| Shareholder Yield % | 19.6 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -101.22 | |||||
| ROA % | -62.63 | |||||
| ROIC % | -252.37 | |||||
| ROC (Joel Greenblatt) % | -351.84 | |||||
| ROCE % | -66.42 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.99 | |||||
| PB Ratio | 1.32 | |||||
| Price-to-Tangible-Book | 1.32 | |||||
| EV-to-EBIT | -0.21 | |||||
| EV-to-EBITDA | -0.22 | |||||
| EV-to-Forward-Revenue | 1.22 | |||||
| EV-to-FCF | -0.22 | |||||
| Price-to-Net-Current-Asset-Value | 1.49 | |||||
| Price-to-Net-Cash | 1.65 | |||||
| Earnings Yield (Greenblatt) % | -476.19 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SURF
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Surface Oncology Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.53 | ||
| Beta | 0.9 | ||
| Volatility % | 72.36 | ||
| 14-Day RSI | 61.5 | ||
| 14-Day ATR ($) | 0.051021 | ||
| 20-Day SMA ($) | 1.00032 | ||
| 12-1 Month Momentum % | -31.44 | ||
| 52-Week Range ($) | 0.555 - 1.43 | ||
| Shares Outstanding (Mil) | 60.82 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Surface Oncology Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Surface Oncology Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Surface Oncology Inc Frequently Asked Questions
What is Surface Oncology Inc(SURF)'s stock price today?
The current price of SURF is $1.07. The 52 week high of SURF is $1.43 and 52 week low is $0.56.
When is next earnings date of Surface Oncology Inc(SURF)?
The next earnings date of Surface Oncology Inc(SURF) is 2023-11-02 Est..
Does Surface Oncology Inc(SURF) pay dividends? If so, how much?
Surface Oncology Inc(SURF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers